Filtrer par catégorie
  • Tous
  • Congress
  • Blog
  • Congrès
  • Ressource Scientifique
  • Webinaire
  • Poster
  • Publication scientifique
  • Communiqué de Presse
  • Couverture presse
  • Actualités
Filtrer par catégorie
Circle Oncodesign Services
Webinaire
28/04/2020

[EN] How to trigger the immune response in anti-tumor therapy? A comprehensive in vitro to in vivo screening platform to identify ICD inducers

Lire la suite
Financial Press Release | Oncodesign
Communiqué de Presse
20/04/2020

Oncodesign announces the creation of its new “Artificial Intelligence” Business Unit and appoints Stéphane Gerart as its Head

Lire la suite
WebinarMRT_website_newspage
Webinaire
02/04/2020

[EN] Simple services or solutions provider: what is the best option to support your drug discovery efforts at preclinical stage?

Outsourcing drug discovery represents a cost-effective opportunity to access specialized technologies & expert scientist resources and provide solutions

Lire la suite
Scientific publications | Oncodesign Services
Publication scientifique
01/04/2020

Single dose pharmacokinetics of intravenous 3,4-dihydroxyphenylacetic acid and 3-hydroxyphenylacetic acid in rats

Single dose pharmacokinetics of intravenous 3,4-dihydroxyphenylacetic acid and 3-hydroxyphenylacetic acid in rats

Lire la suite
Financial Press Release | Oncodesign
Communiqué de Presse
17/02/2020

Oncodesign and Servier reach a key first milestone in their strategic partnership on LRRK2 inhibitors for Parkinson’s Disease

Lire la suite
Scientific publications | Oncodesign Services
Publication scientifique
22/01/2020

G Protein-Coupling of Adhesion GPCRs ADGRE2/EMR2 and ADGRE5/CD97, and Activation of G Protein Signalling by an Anti-EMR2 Antibody

G Protein-Coupling of Adhesion GPCRs ADGRE2/EMR2 and ADGRE5/CD97, and Activation of G Protein Signalling by an Anti-EMR2 Antibody

Lire la suite
Scientific paper - Ressources
Poster
06/01/2020

Development of a panel of breast cancer patient-derived xenograft models (PDX) with estrogen independence and/or acquired resistance to endocrine treatment

Lire la suite
Scientific paper - Ressources
Poster
01/01/2020

ADCs optimization led to a significant anti-tumoral activity in lymphoma and breast tumor xenograft mouse models

Lire la suite
Financial Press Release | Oncodesign
Communiqué de Presse
17/12/2019

Oncodesign announces the selection of its First-in-Class RIPK2 inhibitor drug candidate for auto-immune and inflammatory diseases

Lire la suite
Webinaire
28/11/2019

[EN] How to kick-start the immune response in anti-tumor therapy? A unique screening platform to identify ICD inducers

Lire la suite
Webinaire
24/10/2019

[EN] Conquering sensitive CYPs, UGTs and transporters protein quantification with QTAP analysis

Lire la suite
Financial Press Release | Oncodesign
Communiqué de Presse
24/10/2019

Oncodesign: publication of an article presenting promising results for the treatment of stone man syndrome (FOP)

Lire la suite